Added to YB: 2025-12-26
Pitch date: 2025-12-22
ECOR [neutral]
electroCore, Inc.
+0.41%
current return
Author Info
Planet MicroCap is a global multimedia financial news and publishing company that focuses on delivering news, information and data for public and pre-public microcap companies. Sign up for the newsletter.
Company Info
electroCore, Inc., a bioelectronic medicine and general wellness company, provides non-invasive vagus nerve stimulation (“nVNS”) technology platform in the United States, the United Kingdom, and internationally.
Market Cap
$36.8M
Pitch Price
$4.86
Price Target
N/A
Dividend
N/A
EV/EBITDA
-2.87
P/E
-2.70
EV/Sales
1.16
Sector
Health Care Equipment and Supplies
Category
growth
electroCore (NASDAQ: ECOR): Non-Invasive Nerve Stimulation Products to Rebalance Autonomic Nervous System
ECOR (overview): Non-invasive vagus nerve stimulation devices across 3 channels: prescription (VA/NHS contracts), DTC wellness (Truvaga $499 device), military (tacstim). 7 FDA authorizations for headache/migraine. Key challenge: US insurance coverage. Targeting 2026 profitability, $150-200M revenue long-term.
Read full article (5 min)